anti-CD137 agonistic monoclonal antibody ADG206

{
  "id": "MLC-T-ONC-010231",
  "term": "anti-CD137 agonistic monoclonal antibody ADG206",
  "field": "Oncology and biomedicine",
  "definition": "An Fc-enhanced immunoglobulin G1 (IgG1) monoclonal antibody directed against the costimulatory receptor CD137 (4-1BB; tumor necrosis factor receptor superfamily member 9; TNFRSF9) covalently linked to a peptide mask, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD137 agonistic monoclonal antibody ADG206 is selectively activated in the tumor microenvironment (TME), and targets, binds to, and activates CD137 expressed on a variety of leukocyte subsets including activated T lymphocytes and natural killer (NK) cells. This enhances CD137-mediated signaling, induces cytokine production and promotes T-cell mediated anti-tumor immuneresponses. CD137, a surface glycoprotein of the tumor necrosis factor receptor superfamily, is an inducible costimulatory receptor that plays a key role in T-cell proliferation, survival and cytolytic activity.",
  "synonyms": [
    "anti-CD137 monoclonal antibody ADG206",
    "anti-CD137 agonist monoclonal antibody ADG206",
    "anti-4-1BB agonistic monoclonal antibody ADG206"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/anti-cd137-agonistic-monoclonal-antibody-adg206/"
}